1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. GENinCode Acquires Abcodia

M&A Deal Summary

GENinCode Acquires Abcodia

On September 28, 2022, GENinCode acquired life science company Abcodia from Scottish Equity Partners for 1M EUR

Acquisition Highlights
  • This is GENinCode’s 1st transaction in the Life Science sector.
  • This is GENinCode’s largest (disclosed) transaction.
  • This is GENinCode’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2022-09-28
Target Abcodia
Sector Life Science
Buyer(s) GENinCode
Sellers(s) Scottish Equity Partners
Deal Type Add-on Acquisition
Deal Value 1M EUR

Target

Abcodia

Cambridge, United Kingdom
Abcodia is a clinical-stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. The first product is the ROCA® Test for the early detection of ovarian cancer. Abcodia is based in Cambridge, United Kingdom.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GENinCode

Oxford, United Kingdom
Category Company
Founded 2018
Sector Life Science
Employees42
Revenue 2M GBP (2023)
DESCRIPTION

GENinCode provides advanced genomic technology, products and recommendations fully validated by company's scientific and clinical team. GENinCode goal is to provide doctors and health care practitioners with advanced health information that combines both traditional clinical measures with a patient’s genetic information to provide a comprehensive risk assessment and clinical recommendation to help decision-making. GENinCode was founded in 2018 and is based in Oxford, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Scottish Equity Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2000
Size Large
Type Sector Focused
DESCRIPTION

Scottish Equity Partners is a growth capital firm focused on high-growth tech company invests in the UK and Ireland. The Firm looks to invest up to £25 million across a range of sectors, with a particular interest in enterprise software, consumer internet and tech-enabled service businesses. Scottish Equity seeks to build value by playing an active and supportive role in the growth and development of its portfolio companies. Scottish Equity Partners is based in London.

DEAL STATS #
Overall 14 of 19
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 7 of 10
Country (United Kingdom) 13 of 17
Year (2022) 2 of 2
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-21 Cresset

Litlington, United Kingdom

Cresset provides a software platform that is used by computational and medicinal chemists for small molecule discovery and design. Cresset’s technology allows customers to increase efficiency as well as generate novel ideas, with the ultimate goal of speeding up the discovery and delivery of new drugs. Cresset is based in Litlington, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-19 Pelion

Glasgow, United Kingdom

Pelion is a global Internet of Things (IoT) connectivity platform, providing secure and scalable IoT connectivity for more than 500 enterprise customers. Pelion’s technology enables IoT devices to connect to the optimal cellular network and technology, orchestrated through a platform that allows customers to manage and control deployed devices. Pelion is based in Glasgow, United Kingdom.

Buy -
Mergr

Product

Company

Legal